Michael DiVecchia

Geschäftsführer bei Elicio Therapeutics, Inc. (Old)

Health Technology

Consumer Services

Aktive Positionen von Michael DiVecchia

Unternehmen	Position	Beginn	Ende
Elicio Therapeutics, Inc. (Old) Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA.	Geschäftsführer	-	-

Unternehmen	Position	Beginn	Ende
ELICIO THERAPEUTICS, INC.	Geschäftsführer	01.02.2022	01.01.2024
ELICIO THERAPEUTICS, INC.	Personalreferent	01.02.2022	01.01.2024

Syracuse University

Undergraduate Degree

International

Vereinigte Staaten

Operativ

Sektoral

Health Technology	3
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
ELICIO THERAPEUTICS, INC.	Health Technology

Private Unternehmen	1
Elicio Therapeutics, Inc. (Old) Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA.	Health Technology

Private Unternehmen

Health Technology